Neta Zruya Hashai - 28 Aug 2026 Form 3 Insider Report for Turbogen Ltd. (TRBG)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
31 Aug 2026, 08:11:36 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Neta Zruya Hashai

Key filing fact

Neta Zruya Hashai filed Form 3 for Turbogen Ltd. (TRBG) on 31 Aug 2026.

Key facts

  • This page summarizes Neta Zruya Hashai's Form 3 filing for Turbogen Ltd. (TRBG).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 31 Aug 2026, 08:11.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002122663 Primary reporting owner

Hashai Neta Zruya

Relationship
Chief Financial Officer
Address
22 EFAL STREET, KIRYAT ARYEH, PETAH TIKVA, ISRAEL
Signature
/s/ Neta Zruya Hashai
Signature date
31 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRBG holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
176,875
Date
28 Aug 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRBG holding Derivative

Share option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Aug 2026
Ownership
Direct
Underlying class
Ordinary shares
Underlying amount
150,000
Exercise price
$5.54
Footnotes
F2, F3
TRBG holding Derivative

Share option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Aug 2026
Ownership
Direct
Underlying class
Ordinary shares
Underlying amount
85,000
Exercise price
$6.18
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents (i) 21,875 ordinary shares; (ii) 70,000 restricted share units ("RSUs") granted on October 5, 2025, 31.25% of which vest on and the remaining 68.75% vest in equal quarterly installments of 6.25% thereafter, of which 21,875 RSUs have vested and 48,125 remain unvested as of August 25, 2026; and (iii) 85,000 RSUs granted on April 29, 2026, which vest in equal quarterly installments of 6.25% thereafter, of which 85,000 RSUs remain unvested as of August 25, 2026. Each RSU represents the right to receive one ordinary share.

Footnote F2

A total of 150,000 options were granted on October 5, 2025 and vested in equal quarterly installments of 6.25% beginning May 2, 2025. As of August 25, 2026, 46,875 options are fully vested and none have been exercised into ordinary shares.

Footnote F3

The options were granted with an exercise price of NIS 16.60 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.774 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $5.54 per share.

Footnote F4

A total of 85,000 options were granted on April 29, 2026 and vested in equal quarterly installments of 6.25% beginning April 29, 2027. As of August 25, 2026, none of options are fully vested and none have been exercised into ordinary shares.

Footnote F5

The options were granted with an exercise price of NIS 18.5 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $6.18 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .